Lode Schuerman Selected Research

Pentetic Acid (DTPA)

1/2014	Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.
9/2012	Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
6/2010	Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
10/2009	Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
6/2009	Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).
4/2009	Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
2/2009	Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.
9/2008	Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants.
10/2006	Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of age.
6/2005	Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lode Schuerman Research Topics

Disease

29	Whooping Cough (Pertussis) 01/2022 - 11/2002
28	Diphtheria 01/2022 - 11/2002
27	Tetanus 01/2022 - 11/2002
24	Hepatitis B 01/2022 - 11/2002
12	Poliomyelitis (Polio) 01/2022 - 11/2002
11	Otitis Media 01/2018 - 03/2006
9	Pneumococcal Infections 01/2022 - 03/2007
7	Malaria 04/2022 - 12/2016
5	Fever (Fevers) 06/2010 - 02/2007
3	Infections 01/2022 - 03/2006
3	Pneumonia (Pneumonitis) 01/2022 - 06/2014
2	Measles 01/2020 - 06/2010
2	Rubella (German Measles) 01/2020 - 06/2010
2	Febrile Seizures (Febrile Seizure) 01/2019 - 10/2009
2	Hepatitis 06/2014 - 01/2013
2	Otitis 09/2009 - 03/2006
1	Rare Diseases (Rare Disease) 04/2022
1	Empyema 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	COVID-19 01/2022
1	Rabies (Hydrophobia) 01/2022
1	Yellow Fever 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Cerebral Malaria 01/2019
1	Meningitis 01/2019
1	Vaccine-Preventable Diseases 01/2018
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2018
1	Sudden Infant Death (SID) 01/2017
1	Hepatitis A (Hepatitis, Infectious) 06/2014
1	Pleural Effusion (Pleural Effusions) 06/2014
1	Mumps 06/2010
1	Chickenpox 06/2010
1	Human Influenza (Influenza) 03/2006
1	Haemophilus Infections 03/2006

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 04/2022 - 11/2002
24	Conjugate VaccinesIBA 01/2022 - 01/2005
16	Pentetic Acid (DTPA)FDA LinkGeneric 01/2014 - 11/2002
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
12	AntigensIBA 01/2020 - 01/2004
8	AntibodiesIBA 05/2012 - 01/2004
5	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022 - 09/2005
5	Polysaccharides (Glycans)IBA 09/2016 - 03/2006
5	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2013 - 08/2006
4	Combined VaccinesIBA 12/2011 - 10/2004
4	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 06/2009 - 10/2006
4	Pertussis VaccineIBA 02/2009 - 07/2004
4	Phosphates (Orthophosphate)IBA 10/2006 - 11/2002
3	RTS malaria vaccineIBA 01/2022 - 01/2018
3	Malaria VaccinesIBA 01/2020 - 01/2018
3	Rotavirus VaccinesIBA 01/2020 - 10/2009
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2013 - 03/2006
3	Biological ProductsIBA 02/2011 - 03/2006
3	diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccineIBA 06/2009 - 12/2004
3	ToxoidsIBA 07/2007 - 12/2004
2	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2020 - 07/2007
2	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 01/2020 - 07/2007
2	Carrier Proteins (Binding Protein)IBA 01/2013 - 03/2006
2	PHiD-CV vaccineIBA 09/2012 - 11/2009
2	Immunoglobulin G (IgG)IBA 05/2007 - 03/2007
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020
1	Vitamin A (Retinol)FDA LinkGeneric 01/2020
1	Engerix-BIBA 01/2018
1	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2018
1	10-valent pneumococcal conjugate vaccineIBA 09/2016
1	C-Reactive ProteinIBA 06/2014
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2013
1	ImmunosorbentsIBA 06/2010
1	EnzymesIBA 06/2010
1	AntipyreticsIBA 10/2009
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2009
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 08/2008
1	BoostrixIBA 05/2007
1	Haemophilus influenzae glpQ proteinIBA 03/2007
1	diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccineIBA 08/2006
1	HiberixIBA 03/2006
1	serogroup C meningococcal conjugate vaccineIBA 12/2004
1	pertactin FDA Link 07/2004
1	Hemagglutinins (Hemagglutinin)IBA 07/2004
1	RibitolIBA 11/2002

Therapy/Procedure

2	Middle Ear Ventilation (Tympanostomy) 01/2022 - 01/2018
2	Injections 03/2006 - 11/2002
1	Drug Therapy (Chemotherapy) 01/2022